ReviewJournal of bone oncology2024

The efficacy and applicability of chimeric antigen receptor (CAR) T cell-based regimens for primary bone tumors: A comprehensive review of current evidence.

Atefeh Barzegari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.